The response to your query is detailed below:
| Lucentis (Ranibizumab) Injections | Avastin (Bevacizumab) Injections | Eylea (Aflibercept) Injections
|
Ozudex (Dexamethasone)
Implants |
|
| Total Injections / Implants | 1691 eyes injected (AMD and DMO service combined) | 0 eyes injected | 433 eyes injected (AMD service only, not used for DMO) | N/A |
| OR | ||||
| Vials / Implants | 17 | |||
Does your organisation treat the following conditions ?
| Wet Age Related Macular Degeneration (wAMD) – Yes |
| Visual impairment due to Diabetic Macular Oedema (DMO) – Yes |
| Retinal Vein Occlusion for Central Retinal Vein Occlusion (CRVO) – Yes |
| Retinal Vein Occlusion for Branch Retinal Vein Occlusion (BRVO) – Yes |
| Visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (mCNV) – Yes |
